Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 551-556

  Utsunomiya, Tokuichiro ^a   Kobayashi, Makiko ^a,b   Pollard, Richard B ^a   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRRHIZIC ACID; INTERFERON ANTIBODY; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INFECTION PREVENTION; INFLUENZA VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; LD 50; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS INHIBITION;

EID: 0031035084     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.551     Document Type: Article

References (37)

1. Abe, N., T. Ebina, and N. Ishida. 1982. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol. Immunol. 26:535-539.
2. 2) virus. Chemotherapy (Tokyo) 34:665-671.
3. Baumgarth, N., L. Brown, D. Jackson, and A. Kelso. 1994. Novel features of the respiratory tract T-cell responses to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vitro and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J. Virol. 68:7575-7581.
4. Cate, T. R. 1985. Management of respiratory viral infections: influenza, p. 78-82. In J. Mills and L. Lorey (ed.), Antiviral chemotherapy, new directions for clinical application and research. Elsevier, New York, N.Y.
5. Davies, W. L., R. R. Grun, R. F. Haff, J. W. McGahen, E. M. Neumayer, M. Paulshock, J. C. Watts, E. C. Hermann, and C. E. Hoffman. 1964. Antiviral activity of 1-adamantanamine (amantadine). Science 144:862-863.
6. Dolin, R. 1985. Antiviral chemotherapy and chemoprophylaxis. Science 227: 1296-1303.
7. Finney, R. S. H., and G. H. Somers. 1959. The anti-inflammatory activity of glycyrrhetinic acid and derivatives. J. Pharmacol. 10:613-620.
8. Hattori, T., S. Ikematsu, A. Koito, S. Matsushita, Y. Maeda, M. Hada, M. Fujimaki, and K. Takatsuki. 1989. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res. 11:255-262.
9. Hoshino, A., H. Takenaka, A. Mizukoshi, J. Imanishi, T. Kishida, and M. G. Tovey. 1983. Effect of anti-interferon serum on influenza virus infection in mice. Antiviral Res. 3:59-65.
10. Ishida, N., and F. Suzuki. 1974. Lung consolidations caused by influenza virus infection in mice. Saishin Igaku 29:1194-1201.
11. Ishida, N., Y. Kosaka, and Y. Sasaki. 1959. Studies on experimental influenza in mice. Tohoku J. Exp. Med. 71:151-156.
12. Itoh, K., and K. Kumagai. 1983. Augmentation of NK activity by several anti-inflammatory agents. Excerpta Med. 641:460-464.
13. Kent, J. H., L. E. Chapman, L. M. Schmelts, H. L. Regnery, N. J. Cox, and L. B. Schonberger. 1992. Influenza surveillance - United States, 1991-92. Morbid. Mortal. Weekly Rep. 41:35-46.
14. Knight, V., and B. E. Gilbert. 1987. Rebavirin aerosol treatment of influenza. Infect. Dis. Clin. N. Am. 1:441-457.
15. Kumagai, A., S. Yano, M. Otomo, and K. Takeuchi. 1957. Study on the corticoid-like action of glycyrrhizine and the mechanism of its action. Endocrinol. Jpn. 4:9-19.
16. Numazaki, K., N. Nagata, T. Sato, and S. Chiba. 1994. Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor α on infection of U-937 and MRC-5 cells by human cytomegalovirus. J. Leukocyte Biol. 55:24-28.
17. Perrotta, D. M., M. Decker, and W. P. Glezen. 1985. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am. J. Epidemiol. 122:468-476.
18. Pompei, R., O. Flore, M. A. Marccialis, A. Pani, and B. Loddo. 1979. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281:689-690.
19. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497.
20. Saito, N., F. Suzuki, K. Sasaki, and N. Ishida. 1976. Antiviral and interferon-inducing activity of a new glutarimide antibiotic, 9-methylstreptimidone. Antimicrob. Agents Chemother. 10:14-19.
21. Saito, N., F. Suzuki, and N. Ishida. 1983. Antiviral effect of interferon on influenza virus infection in mice. Tohoku J. Exp. Med. 139:355-363.
22. 2 virus. Microbiol. Immunol. 25:173-181.
23. Sarawar, S., and P. C. Doherty. 1994. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J. Virol. 68:3112-3119.
24. Shimomura, E., F. Suzuki, and N. Ishida. 1982. Characterization of cells infiltrating the lungs of X-irradiated and nude mice after influenza virus infection. Microbiol. Immunol. 26:129-138.
25. Shinada, M., M. Azuma, H. Kawai, K. Sazaki, I. Yoshida, T. Yoshida, T. Suzutani, and T. Sakuma. 1986. Enhancement of interferon-γ production in glycyrrhizin-treated, human peripheral lymphocytes in response to concanavalin A and surface antigen of hepatitis B virus. Proc. Soc. Exp. Biol. Med. 181:205-210.
26. Suzuki, F., T. Koide, A. Tsunoda, and N. Ishida. 1974. Mushroom extract as an interferon inducer. I. Biological and physicochemical properties of spore extracts of Lentinus edodes. Mushroom Sci. 9:509-519.
27. Suzuki, F., J. Ohya, and N. Ishida. 1974. Effect of antilymphocyte serum on influenza virus infection in mice. Proc. Soc. Exp. Biol. Med. 146:78-84.
28. Suzuki, F., N. Ishida, M. Suzuki, T. Sato, and S. Suzuki. 1975. Effect of the interferon inducer, dextran phosphate, on influenza virus infection in mice. Proc Soc. Exp. Biol. Med. 149:1069-1075.
29. Suzuki, F., N. Saito, and N. Ishida. 1975. The protective effects of several interferon inducers on influenza virus infection in mice. Saishin Igaku 30: 1078-1084.
30. Suzuki, F., N. Saito, and N. Ishida. 1976. Antiviral effects of the interferon and interferon inducers in experimental animals. Protein, Nucleic Acid, Enzyme 21:260-270.
31. Suzuki, F., and N. Ishida. 1977. Effective mechanisms of interferon and their inducers in vivo. Jpn. J. Clin. Med. 35:136-141.
32. Suzuki, F., C. Suzuki, E. Shimomura, H. Maeda, T. Fujii, and N. Ishida. 1979. Antiviral and interferon-inducing activities of a new peptidomannan, KS-2, extracted from culture mycelia Lentinus edodes. J. Antibiot. 32:1336-1345.
33. Suzuki, F., and R. B. Pollard. 1982. Mechanism for the suppression of γ-interferon responsiveness in mice after thermal injury. J. Immunol. 129: 1811-1815.
34. Suzuki, H., Y. Ohta, T. Takino, K. Fujisawa, and C. Hirayama. 1983. Effects of glycyrrhizin on biomedical tests in patients with chronic hepatitis - double blind trial. Asian Med. J. 26:423-438.
35. Tobita, K., A. Sugiura, C. Enomoto, and M. Furuyama. 1975. Plaque assay and primary isolation of influenza A virus in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. 162:9-14.
36. Utsunomiya, T., M. Kobayashi, R. B. Pollard, and F. Suzuki. 1994. Pulmonary consolidations in influenza virus-infected mice treated with glycyrrhizin, abstr. E21, p. 147. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
37. Utsunomiya, T., M. Kobayashi, D. N. Herndon, R. B. Pollard, and F. Suzuki. 1995. Glycyrrhizin (20β-carboxy-11-oxo-30-norolean-12-en-3β-y1-2-O-β-D- glucopyranuronosyl-α-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol. Lett. 44:59-66.